114 related articles for article (PubMed ID: 17900657)
1. Primary tumor/vessel tumor/nodal tumor classification of extrahepatic bile duct carcinoma.
Hasebe T; Konishi M; Iwasaki M; Nakagohri T; Takahashi S; Gotohda N; Kinoshita T; Ochiai A
Hum Pathol; 2008 Jan; 39(1):37-48. PubMed ID: 17900657
[TBL] [Abstract][Full Text] [Related]
2. Histological characteristics of tumor cells and stromal cells in vessels and lymph nodes are important prognostic parameters of extrahepatic bile duct carcinoma: a prospective study.
Hasebe T; Konishi M; Iwasaki M; Endoh Y; Nakagohri T; Takahashi S; Kinoshita T; Ochiai A
Hum Pathol; 2005 Jun; 36(6):655-64. PubMed ID: 16021572
[TBL] [Abstract][Full Text] [Related]
3. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response.
Oshikiri T; Miyamoto M; Shichinohe T; Suzuoki M; Hiraoka K; Nakakubo Y; Shinohara T; Itoh T; Kondo S; Katoh H
J Surg Oncol; 2003 Dec; 84(4):224-8. PubMed ID: 14756433
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma.
Murakami S; Miyamoto M; Hida Y; Cho Y; Fukunaga A; Oshikiri T; Kato K; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Itoh T; Shinohara T; Morikawa T; Okushiba O; Kondo S; Katoh H
Br J Cancer; 2003 Apr; 88(8):1234-8. PubMed ID: 12737162
[TBL] [Abstract][Full Text] [Related]
6. Prognostic determinants in extrahepatic bile duct cancer.
Kurosaki I; Tsukada K; Watanabe H; Hatakeyama K
Hepatogastroenterology; 1998; 45(22):905-9. PubMed ID: 9755978
[TBL] [Abstract][Full Text] [Related]
7. The mode of lymphatic spread in carcinoma of the bile duct.
Kurosaki I; Tsukada K; Hatakeyama K; Muto T
Am J Surg; 1996 Sep; 172(3):239-43. PubMed ID: 8862075
[TBL] [Abstract][Full Text] [Related]
8. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma.
Hirashima K; Iyama K; Baba Y; Honda Y; Sado Y; Ninomiya Y; Watanabe M; Takamori H; Beppu T; Baba H
J Surg Oncol; 2013 Mar; 107(4):402-7. PubMed ID: 22927259
[TBL] [Abstract][Full Text] [Related]
10. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for radical resection of middle and distal bile duct cancer.
Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
[TBL] [Abstract][Full Text] [Related]
12. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
[TBL] [Abstract][Full Text] [Related]
15. Measurement of the invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system.
Hong SM; Cho H; Moskaluk CA; Yu E
Am J Surg Pathol; 2007 Feb; 31(2):199-206. PubMed ID: 17255764
[TBL] [Abstract][Full Text] [Related]
16. Correlation of glycosyltransferases mRNA expression in extrahepatic bile duct carcinoma with clinical pathological characteristics.
Jin XL; Zheng SS; Wang BS; Chen HL
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):292-5. PubMed ID: 15138129
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.
Thelen A; Scholz A; Benckert C; Weichert W; Dietz E; Wiedenmann B; Neuhaus P; Jonas S
Ann Surg Oncol; 2008 Mar; 15(3):791-9. PubMed ID: 18172731
[TBL] [Abstract][Full Text] [Related]
18. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of lymphocytic infiltration and character of invasive margin following total mesorectal excision with sphincter preservation for the high-risk carcinoma of the rectum.
Szynglarewicz B; Matkowski R; Suder E; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z
Adv Med Sci; 2007; 52():159-63. PubMed ID: 18217410
[TBL] [Abstract][Full Text] [Related]
20. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
